About US
Contact us
-
Astellas and Proteostasis partner to develop therapeutic candidates for UPRJapan-based Astellas Pharma has partnered with Proteostasis Therapeutics for research, development and commercialisation of therapies, which modulate the unfolded protein response (UPR). Under the de2014/11/6
-
Bayer acquires Chinese Dihon Pharmaceutical for €460mGermany-based Bayer has completed the acquisition of China-based Dihon Pharmaceutical Group, for CNY3.6bn (€460m). Dihon produces over-the-counter (OTC) dermatology products and herbal traditional Ch2014/11/5
-
Pharming and Salix introduce acute angioedema treatment Ruconest in USPharming Group and Salix Pharmaceuticals have introduced Ruconest (C1 esterase inhibitor [recombinant]) 50IU/kg in the US, a treatment developed to treat acute angioedema attacks in adult and adolesce2014/11/5
-
Arena narrows loss as Belviq sales pick upArena Pharmaceuticals ($ARNA), developer of the weight-loss drugBelviq, is not exactly getting fat off of its sales, but it is making progress. With a marketing push from partnerEisaibehind it, the dr2014/11/5
-
Eleventh API China pharmaceutical excipients ForumEleventh API China pharmaceutical excipients Forum Pharmaceutical excipients and food additives’ quality standard seminar Time: November 28, 2014 9: 00-16: 30 Venue: China Import and Export Fa2014/11/5
-
2014'PHEXTOUR– Zhuhai Station2014'PHEXTOUR Pharmaceutical Excipients Application Technology (Greater China) Tour Seminars– Zhuhai Station Publisher: phexcom Published: 2014/10/28 10:42:08 2014'PHEXTOUR Pharmaceutical Excipie2014/11/4
-
Bristol-Myers Squibb expands biologics manufacturing agreement with LonzaBristol-Myers Squibb (BMS) has expanded its existing biologics manufacturing agreement with Switzerland-based Lonza. The contract is expanded for the production of commercial quantities of a second B2014/11/4
-
Genmab signs ofatumumab transfer agreement with GSK and NovartisDenmark-based Genmab has signed an agreement with British drug-maker GlaxoSmithKline (GSK) and Swiss pharmaceutical company Novartis for the conditional transfer of ofatumumab collaboration contract f2014/11/4
-
CFDA, General Administration of Customs and General Administration of Sport jointly issue Administrative Measures for Import and Export of Anabolic Agents and Peptide HormonesIn accordance with the relevant requirements of the State Council on deepening the reform of administrative approval system, the approval of the import of anabolic agents and peptide hormones is autho2014/11/4
-
British-Swedish drugmaker AstraZeneca has received approval from US Food and Drug Administration (FDA) for its once-daily Xigduo XR to treat adult patients with type 2 diabetes.British drug-maker GlaxoSmithKline (GSK) has introduced a new once-daily bronchodilator treatment, Incruse Ellipta (umeclidinium) in the UK. A long-acting muscarinic antagonist (LAMA), Incruse has be2014/11/3